Point72 Asset Management, L.P. 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:32 pm Purchase | 2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Point72 Asset Management, L.P. | 472,864 2.200% | 46,702 (+10.96%) | Filing |
| 2021-02-16 3:09 pm Purchase | 2020-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Point72 Asset Management, L.P. | 426,162 10.900% | 426,162 (New Position) | Filing |